Results 211 to 220 of about 26,478 (271)

Cardioprotective Mechanisms of Beta-Blockers in Myocardial Ischemia and Reperfusion: From Molecular Targets to Clinical Implications. [PDF]

Int J Mol Sci
Nasoufidou A, Bantidos MG, Fyntanidou B, Kofos C, Stachteas P, Arvanitaki A, Karakasis P, Sagris M, Kassimis G, Fragakis N, Karagiannidis E.   +10 more
europepmc   +1 more source

Decoding GPCR signaling in living cells to advance early therapeutic discovery for neurological disorders. [PDF]

Front Mol Neurosci
Palladino G, Patarra R, Li Z, Rossner MJ, Wehr MC.   +4 more
europepmc   +1 more source

Growth Differentiation Factor-15 in Diabetic Kidney and Cardiovascular Disease: Pathogenic Driver or Protective Modulator. [PDF]

Diabetes
Slika A, Noureddine M, Jomaa D, Abboud EE, Zaidan S, Azar S, Ziyadeh F, Njeim R, Eid AA.   +8 more
europepmc   +1 more source

The impact of inflammation, neuromodulation, and gut microbiota on developing cardiac fibrosis and hypertension. [PDF]

Cardiovasc Res
Kozdrowicki M, Szczepaniak P, Kyslyi V, Carnevale L, Carnevale D, Lembo G, Guzik TJ, Mikołajczyk TP.   +7 more
europepmc   +1 more source

Effects of catecholamines on bone and mineral metabolism in patients with pheochromocytoma and paraganglioma.

J Clin Endocrinol Metab
Alkaissi H, Pacak K, Gordon CM.
europepmc   +1 more source

Isoprenaline alleviates diabetic kidney disease via multi-target inhibition of the cGAS-STING pathway. [PDF]

Biosci Rep
Ma R, Song Y, Zhang L, Wang P, Chen J, Chen T, Zhu G, Pan Q, Ma M, Mo Q, Lu S, Yu X, Guo Y.   +12 more
europepmc   +1 more source

Therapeutic Potential of the β3-Adrenergic Receptor and Its Ligands in Cardiovascular Diseases. [PDF]

Int J Mol Sci
Kempiński M, Jańczak P, Porębska A, Zawadzka PS, Jastrzębska P, Granat MM, Wojciechowska M.   +6 more
europepmc   +1 more source

Peripheral nerve remodeling in the tumor microenvironment: neuro-immune crosstalk, molecular mechanisms, and precision therapeutic. [PDF]

Front Immunol
Liu H, Li X, Yu J, Chen T.
europepmc   +1 more source